Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Inventory: 2009-2024

Historic Change in Inventory for Anika Therapeutics (ANIK) over the last 16 years, with Dec 2024 value amounting to $9.4 million.

  • Anika Therapeutics' Change in Inventory fell 85.25% to $443,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 128.09%. This contributed to the annual value of $9.4 million for FY2024, which is 17.30% down from last year.
  • Anika Therapeutics' Change in Inventory amounted to $9.4 million in FY2024, which was down 17.30% from $11.4 million recorded in FY2023.
  • Over the past 5 years, Anika Therapeutics' Change in Inventory peaked at $14.2 million during FY2020, and registered a low of $6.6 million during FY2021.
  • For the 3-year period, Anika Therapeutics' Change in Inventory averaged around $9.2 million, with its median value being $9.4 million (2024).
  • In the last 5 years, Anika Therapeutics' Change in Inventory surged by 153.84% in 2020 and then crashed by 53.31% in 2021.
  • MRY analysis of 5 years shows Anika Therapeutics' Change in Inventory stood at $14.2 million in 2020, then crashed by 53.31% to $6.6 million in 2021, then increased by 3.84% to $6.9 million in 2022, then surged by 65.81% to $11.4 million in 2023, then decreased by 17.30% to $9.4 million in 2024.
  • Its Change in Inventory was $9.4 million in FY2024, compared to $11.4 million in FY2023 and $6.9 million in FY2022.